MSP Recovery, Inc. Price & Performance (MSPRW)

StoneCo has emerged as a stronger investment compared to MSP Recovery, outperforming in profitability, valuation, and institutional ownership. With a net margin of 16.02% and a price-to-earnings ratio of 7.59, StoneCo shows robust financial health. Analysts also favor StoneCo, giving it a higher consensus rating and a potential upside of 48%.1

MSP Recovery's stock has dropped 7.5%, trading at $1.97, a significant decline from its previous close. With a market cap of $12.93 million and a beta of -2.38, the company struggles with volatility. Recent institutional activity highlights a hedge fund acquiring a small stake, reflecting cautious investor sentiment.2

Change Healthcare is grappling with lawsuits stemming from a massive ransomware attack that compromised 190 million individuals' data. A judge has set a March 2025 deadline for motions to dismiss claims. Settlement talks are underway, but if unresolved, bellwether trials may shape the litigation's outcome.3